Do you want to read an article? Please log in or register.
Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis.
Related content
First experience in Switzerland in Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease enrolled in a lumacaftor-ivacaftor therapy trial - preliminary results
Swiss Med Wkly.
Murer C, Huber LC, Kurowski T, Hirt A, Robinson CA, Bürgi U, Benden C
doi: 10.4414/smw.2018.14593.
Pulmonary Fibrosis
Supersonic shear-wave elastography and APRI for the detection and staging of liver disease in pediatric cystic fibrosis
J Cyst Fibros.
Calvopina DA, Noble C, Weis A, Hartel GF, Ramm LE, Balouch F, Fernandez-Rojo MA, Coleman MA, Lewindon PJ, Ramm GA
doi: 10.1016/j.jcf.2019.06.017.
Pulmonary Fibrosis
Initial clinical evaluation of stationary digital chest tomosynthesis in adult patients with cystic fibrosis
Eur Radiol.
Gunnell ET, Franceschi DK, Inscoe CR, Hartman A, Goralski JL, Ceppe A, Handly B, Sams C, Fordham LA, Lu J, Zhou O, Lee YZ
doi: 10.1007/s00330-018-5703-9.
RECOMMENDED
Pulmonary Fibrosis
Disease Severity and Quality of Life in Patients with Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry: Disease severity and quality of life in IPF
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest.
O'Brien EC, Hellkamp AS, Neely ML, Swaminathan A, Bender S, Snyder LD, Culver DA, Conoscenti CS, Todd JL, Palmer SM, Leonard TB, IPF-PRO™ Registry investigators
doi: 10.1016/j.chest.2019.11.042.
Pulmonary Fibrosis
Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients
Pediatr Pulmonol.
Bruch BA, Singh SB, Ramsey LJ, Starner TD
doi: 10.1002/ppul.24024.
Pulmonary Fibrosis
Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
N Engl J Med.
Taylor-Cousar JL, Munck A, McKone EF, van der Ent CK, Moeller A, Simard C, Wang LT, Ingenito EP, McKee C, Lu Y, Lekstrom-Himes J, Elborn JS
doi: 10.1056/
RECOMMENDED
Pulmonary Fibrosis
Rapid Improvement After Starting Elexacaftor-tezacaftor-ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Am J Respir Crit Care Med
Burgel PR, Durieu I, Chiron R, Ramel S, Danner-Boucher I, Prevotat A, Grenet D, Marguet C, Reynaud-Gaubert M, Macey J, Mely L, Fanton A, Quetant S, Lemonnier L, Paillasseur JL, Da Silva J, Martin C, French Cystic Fibrosis Reference Network study group.
doi: 10.1164/rccm.202011-4153OC
RECOMMENDED
Pulmonary Fibrosis
The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros.
Havermans T, Houben J, Vermeulen F, Boon M, Proesmans M, Lorent N, de Soir E, Vos R, Dupont L
doi: 10.1016/j.jcf.2020.07.022.
Pulmonary Fibrosis
Tracheal diverticula in advanced cystic fibrosis: Prevalence, features, and outcomes after lung transplantation
J Cyst Fibros.
Kapnadak SG, Kicska GA, Ramos KJ, Marshall DA, Carroll TY, Pipavath SN, Mulligan MS, Goss CH, Aitken ML
doi: 10.1016/j.jcf.2017.07.015.